Senator Collins Warns Trump Administration on NIH Funding
Senator Susan Collins is voicing concerns over what she describes as an attempt by the Trump administration to politicize funding for federal health research. This comes during a heated race for her Senate seat, with recent polls indicating a highly competitive contest.
Democrat Troy Jackson currently has a slight lead over Collins. A CNN/SSRS poll shows Jackson ahead with 48 percent to Collins’ 45 percent. Other polls also indicate a tight race, with election forecasters rating it a toss-up.
Controversy Over NIH Grant Control
The dispute began after reports emerged that President Trump might sign an executive order to create a commission to review NIH grants. This panel could allow political appointees to influence the allocation of nearly $50 billion in research funding. White House budget chief Russell Vought criticized the NIH, suggesting that it funded initiatives misaligned with Trump’s priorities.
Responding to this on Monday, Collins stated, “The Office of Management and Budget (OMB) should not interfere in grant award decisions.” She further warned that any politicization of NIH grants contradicts congressional intentions. Collins emphasized that introducing political evaluations undermines scientifically vetted awards.
History of Opposition
Collins’ concerns are not new. In a July letter to Vought, she criticized a proposed grant-making rule requiring political appointees to review grants already evaluated for scientific merit. Collins argued this would shift focus from science to ideology.
She also opposed provisions that would let agencies terminate grants misaligned with national interests, fearing it could halt clinical trials and deter long-term research.
Oval Office Tensions
An Oval Office meeting reportedly saw tensions between Trump, Vought, and NIH Director Jay Bhattacharya. Vought proposed more oversight on NIH grants, but Bhattacharya defended the current review process.
NIH spokesman Joshua Pradko commented that no NIH grant funds would be rescinded, reassuring continued investment in biomedical research.
Bipartisan Criticism
Lawmakers from both parties have criticized the potential executive order. Senator Patty Murray emphasized that medical research funding decisions should rest with NIH experts, not political appointees. She urged Republicans to resist such politicization efforts.
As the NIH dispute unfolds, Collins faces challenges in her re-election bid. Polling highlights a close race against Jackson, compounded by Trump’s low approval ratings in Maine.
For inquiries, please reach out to Newsweek editor Edward T. Cummins.